# US 2021/0079368 A9 · Compositions Comprising Polypeptides Having Xylanase Activity and Polypeptides Having Arabinofuranosidase Activity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0079368 A9
- Document ID: US20210079368A9
- Status: Published application
- Kind: A9
- Application number: 16/887,004
- Filed: 2020-05-29
- Published: 2021-03-18
- Earliest claimed: 2014-12-19
- Assignees: Novozymes A/S
- Applicants: Novozymes A/S
- Inventors: Wei Peng; Ninfa Rangel Pedersen; Dan Pettersson; Jens Magnus Eklof; Soren Nymand-Grarup; Lorena G. Palmen; Rune Nygaard Monrad; Nikolaj Spodsberg; Mary Ann Stringer; Charlotte Blom; Lars Kiemer; Kristian Bertel Romer M. Krogh; Jesper Salomon
- Web page: https://patentgrep.com/patent/US20210079368A9

## CPC

- C12N 9/248: {Xylanases}
- A23K 10/14: Pretreatment of feeding-stuffs with enzymes
- C12N 9/24: acting on glycosyl compounds (3.2)
- C12N 9/2402: {hydrolysing O- and S- glycosyl compounds (3.2.1)}
- C12P 19/14: produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase}
- C12Y 302/01008: Endo-1,4-beta-xylanase (3.2.1.8)
- C12Y 302/01055: Alpha-N-arabinofuranosidase (3.2.1.55)
- C07K 2319/02: containing a signal sequence
- C07K 2319/20: containing a tag with affinity for a non-protein ligand
- C07K 2319/21: containing a His-tag
- C07K 2319/55: containing a fusion with a toxin, e.g. diphteria toxin
- Y02E 50/10: Biofuels, e.g. bio-diesel
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A23K: FODDER
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- Y02E: REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION

## Abstract

The present invention relates to compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity for use in, e.g., animal feed. The present invention further relates to polypeptides having arabinofuranosidase activity, polypeptides having xylanase activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.

## Claims

### Claim 1

A composition comprising one or more GH10 or GH11 polypeptides having xylanase activity and one or more GH62 polypeptides having arabinofuranosidase activity, wherein:
(a) the GH62 polypeptide comprises the motif [H/Y][L/M]F[F/S][A/C/H/S/TN][A/D/G/N/R]D[D/E/N]G (SEQ ID NO: 1);
(b) the GH10 or GH11 polypeptide and the GH62 polypeptide together solubilise at least 2.0% xylose from defatted destarched maize (DFDSM); and
(c) the GH10 or GH11 polypeptide and the GH62 polypeptide together solubilise at least 2 times more xylose from DFDSM than the GH10 or GH11 polypeptide can when the GH62 polypeptide is not present;
wherein (b) and (c) are performed under the reaction conditions:
i) 25 mg GH10 or GH11 polypeptide per kg DFDSM,
ii) 12.5 mg GH62 polypeptide per kg DFDSM, and
iii) incubation at 40° C., pH 5 for 4 hours.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the GH62 polypeptide comprises one or more motifs selected from the list consisting of [H/Y]LF[F/S][A/SN][A/D/G]DNG (SEQ ID NO: 2), YLFF[A/V][A/G]DNG (SEQ ID NO: 3), YLFFAGDNG (SEQ ID NO: 4), [H/Y]LFSSDDNG (SEQ ID NO: 5), and YLFSSDDNG (SEQ ID NO: 6).

### Claim 3 (depends on 1)

The composition of claim 1, wherein the GH62 polypeptide having arabinofuranosidase activity is selected from the group consisting of:
(a) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 9;
(b) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 12;
(c) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 15;
(d) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 18;
(e) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 21;
(f) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 24;
(g) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 27;
(h) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 30;
(i) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 36;
(j) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 42;
(k) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 48;
(l) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 54;
(m) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 60;
(n) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 66;
(o) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 105;
(p) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 108;
(q) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 114;
(r) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 120;
(s) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 123;
(t) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 126;
(u) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 132;
(v) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 138;
(w) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 141;
(x) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 147;
(y) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 150;
(z) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 156;
(aa) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 159;
(ab) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 162;
(ac) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 165;
(ad) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 168;
(ae) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 171;
(af) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 174;
(ag) a variant of the polypeptide selected from the group consisting of SEQ ID NO: 9, SEQ ID NO: 12, SEQ ID NO: 15, SEQ ID NO: 18, SEQ ID NO: 21, SEQ ID NO: 24, SEQ ID NO: 27, SEQ ID NO: 30, SEQ ID NO: 36, SEQ ID NO: 42, SEQ ID NO: 48, SEQ ID NO: 54, SEQ ID NO: 60, SEQ ID NO: 66 SEQ ID NO: 105, SEQ ID NO: 108, SEQ ID NO: 114, SEQ ID NO: 120, SEQ ID NO: 123, SEQ ID NO: 126, SEQ ID NO: 132, SEQ ID NO: 138, SEQ ID NO: 141, SEQ ID NO: 147, SEQ ID NO: 150, SEQ ID NO: 156, SEQ ID NO: 159, SEQ ID NO: 162, SEQ ID NO: 165, SEQ ID NO: 168, SEQ ID NO: 171 and SEQ ID NO: 174 wherein the variant has arabinofuranosidase activity and comprises one or more amino acid substitutions, and/or one or more amino acid deletions, and/or one or more amino acid insertions or any combination thereof in 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 positions;
(ah) a polypeptide comprising the polypeptide of (a), (b), (c), (d), (e), (f), (g), (h), (i), (j), (k), (l), (m), (n), (o), (p), (q), (r), (s), (t), (u), (v), (w), (x), (y), (z), (aa), (ab), (ac), (ad), (ae), (af) or (ag) and a N-terminal and/or C-terminal His-tag and/or HQ-tag; and
(ai) a fragment of the polypeptide of (a), (b), (c), (d), (e), (f), (g), (h), (i), (j), (k), (l), (m), (n), (o), (p), (q), (r), (s), (t), (u), (v), (w), (x), (y), (z), (aa), (ab), (ac), (ad), (ae), (af), (ag) or (ah) having arabinofuranosidase activity and having at least 90% of the length of the mature polypeptide.

### Claim 4

(canceled)

### Claim 5 (depends on 1)

The composition of claim 1, wherein the GH10 or GH11 polypeptide having xylanase activity is selected from the group consisting of:
(a) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 70;
(b) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 71;
(c) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 72;
(d) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 73;
(e) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 74;
(f) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 75;
(g) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 78;
(h) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 81;
(i) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 84;
(j) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 88;
(k) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 89;
(l) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ I D NO: 95;
(m) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 96;
(n) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 99;
(o) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 102;
(p) a polypeptide having at least 80% sequence identity to the polypeptide of SEQ ID NO: 177;
(q) a variant of the polypeptide selected from the group consisting of SEQ ID NO: 70, SEQ ID NO: 71, SEQ ID NO: 72, SEQ ID NO: 73, SEQ ID NO: 74, SEQ ID NO: 75, SEQ ID NO: 78, SEQ ID NO: 81, SEQ ID NO: 84, SEQ ID NO: 88, SEQ ID NO: 89, SEQ ID NO: 95, SEQ ID NO: 96, SEQ ID NO: 99, SEQ ID NO: 102 and SEQ ID NO: 177 wherein the variant has xylanase activity and comprises one or more amino acid substitutions, and/or one or more amino acid deletions, and/or one or more amino acid insertions or any combination thereof in 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 positions;
(r) a polypeptide comprising the polypeptide of (a), (b), (c), (d), (e), (f), (g), (h), (i), (j), (k), (l), (m), (n), (o), (p) or (q) and a N-terminal and/or C-terminal His-tag and/or HQ-tag; and
(s) a fragment of the polypeptide of (a), (b), (c), (d), (e), (f), (g), (h), (i), (j), (k), (l), (m), (n), (o), (p), (q) or (r) having xylanase activity and having at least 90% of the length of the mature polypeptide.

### Claim at position 6

6-12. (canceled)

### Claim 13 (depends on 1)

The composition of claim 1, further comprising one or more formulating agents, one or more additional enzymes and/or one or more microbes.

### Claim 14 (depends on 1)

An animal feed additive comprising the composition of claim 1 and one or more components selected from the list consisting of:
one or more vitamins;
one or more minerals;
one or more amino acids; and
one or more other feed ingredients.

### Claim 15 (depends on 1)

An animal feed comprising the composition of claim 1 and plant based material from the sub-family Panicoideae.

### Claim 16 (depends on 1)

A method of improving one or more performance parameters of an animal comprising administering to one or more animals the composition of claim 1.

### Claim 17 (depends on 1)

A method of solubilising xylose from plant based material, comprising treating plant based material from the sub-family Panicoideae with the composition of claim 1.

### Claim 18 (depends on 1)

A method of releasing starch from plant based material, comprising treating plant based material from the sub-family Panicoideae with the composition of claim 1.

### Claim 19 (depends on 1)

A method for improving the nutritional value of an animal feed, comprising adding to the feed the composition of claim 1.

### Claim 20 (depends on 1)

A method of preparing an animal feed, comprising mixing the composition of claim 1 with plant based material from the sub-family Panicoideae.

### Claim at position 15

21-30. (canceled)
